38th week of 2018 patent applcation highlights part 8 |
Patent application number | Title | Published |
20180263877 | COSMETIC COMPOSITION COMPRISING A PEPPERMINT EXTRACT | 2018-09-20 |
20180263878 | DYE COMPOSITION COMPRISING A PARA-PHENYLENEDIAMINE OXIDATION BASE AND A PARTICULAR COUPLER | 2018-09-20 |
20180263879 | SULFATE-FREE FORMULATIONS | 2018-09-20 |
20180263880 | SELF-HEATING AGENTS FOR REDUCTIVE DECOLORIZATION OF DYED KERATINOUS FIBERS | 2018-09-20 |
20180263881 | AGENT FOR DECOLORIZING DYED KERATINOUS FIBERS | 2018-09-20 |
20180263882 | AGENT FOR HAIR DEFORMING TREATMENT | 2018-09-20 |
20180263883 | MICROEMULSION-TYPE COSMETIC AND METHOD FOR MANUFACTURING SAME | 2018-09-20 |
20180263884 | Foundation cream/liquid with controllable color change | 2018-09-20 |
20180263885 | Oral Care Compositions and Methods of Use | 2018-09-20 |
20180263886 | PERSONAL CARE PRODUCTS COMPRISING HIGHLY CATIONIC SUBSTITUTED STARCHES | 2018-09-20 |
20180263887 | TOPICAL COMPOSITIONS CONTAINING CROSS-LINKED GLYCOSAMINOGLYCANS | 2018-09-20 |
20180263888 | CONCENTRATED POLYOLEFIN EMULSIONS AND HAIR CARE COMPOSITIONS CONTAINING THEM | 2018-09-20 |
20180263889 | COMPOSITION COMPRISING STABILIZED POLYMER PARTICLES AND A NONIONIC SURFACTANT | 2018-09-20 |
20180263890 | ANHYDROUS LIQUID COMPOSITION COMPRISING OILS, A FILM-FORMING POLYMER, A MONOALCOHOL AND A PARTICULATE MATERIAL | 2018-09-20 |
20180263891 | USE OF UV RESISTANT ACTIVE MATERIALS ON HAIR | 2018-09-20 |
20180263892 | TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS | 2018-09-20 |
20180263893 | TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS | 2018-09-20 |
20180263894 | COSMETIC COMPOSITIONS AND METHODS | 2018-09-20 |
20180263895 | COSMETIC COMPOSITIONS AND METHODS OF THEIR USE | 2018-09-20 |
20180263896 | FORMULATION AND MANUFACTURE OF PHARMACEUTICALS BY IMPREGNATION ONTO POROUS CARRIERS | 2018-09-20 |
20180263897 | DICLOFENAC FORMULATIONS | 2018-09-20 |
20180263898 | CONCENTRATED PROTEIN FORMULATIONS AND USES THEREOF | 2018-09-20 |
20180263899 | INTRAUTERINE DELIVERY SYSTEM FOR CONTRACEPTION | 2018-09-20 |
20180263900 | SUSTAINED DRUG-RELEASE CONTACT LENS | 2018-09-20 |
20180263901 | TIME-RELEASE AND MICRO-DOSE FORMULATIONS FOR TOPICAL APPLICATION OF ESTROGEN AND ESTROGEN ANALOGS OR OTHER ESTROGEN RECEPTOR MODULATORS IN THE TREATMENT OF DRY EYE SYNDROME, AND METHODS OF PREPARATION AND APPLICATION | 2018-09-20 |
20180263902 | Process For Making Tablet Using Radiofrequency | 2018-09-20 |
20180263903 | ORAL PARTICULATE COMPOSITION | 2018-09-20 |
20180263904 | CHEWABLE GEL PRODUCTS FOR ACTIVE PHARMACEUTICAL INGREDIENTS | 2018-09-20 |
20180263905 | Manufacturing of Semi-Plastic Pharmaceutical Dosage Units | 2018-09-20 |
20180263906 | NRF2 Screening Assays and Related Methods and Compositions | 2018-09-20 |
20180263907 | Lipid Particle Formulations for Delivery of RNA and Water-Soluble Therapeutically Effective Compounds to a Target Cell | 2018-09-20 |
20180263908 | COMPOSITION FOR PREVENTING OR TREATING ISCHEMIC DISEASES, CONTAINING LIPOSOMES IN WHICH VEGF-DERIVED PEPTIDES ARE SUPPORTED | 2018-09-20 |
20180263909 | DUAL LOADED LIPOSOMAL NANOPARTICLES | 2018-09-20 |
20180263910 | MULTI-COMPONENT NANOCONSTRUCTS | 2018-09-20 |
20180263911 | Sustained Release Olanzapine Formulations | 2018-09-20 |
20180263912 | METHOD FOR PREPARING ITRACONAZOLE PREPARATION | 2018-09-20 |
20180263913 | Modified Release Multi-Layer Tablet Cannabinoid Formulations | 2018-09-20 |
20180263914 | COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS | 2018-09-20 |
20180263915 | Pharmaceutical Composition for Oral GLP-1 Administration Comprising a Tablet Core and Immediate Release Coating | 2018-09-20 |
20180263916 | SOFT GELATIN CAPSULES CONTAINING A MIXTURE OF ANALGESICS AND DECONGESTANTS, EXPECTORANTS, ANTITUSSIVES AND/OR ANTIHISTAMINES | 2018-09-20 |
20180263917 | SINGLE SOLID ORAL DOSAGE FORMS FOR TREATING HELICOBACTER PYLORI INFECTION AND DUODENAL ULCER DISEASE | 2018-09-20 |
20180263918 | ENCAPSULATION OF MESSENGER RNA | 2018-09-20 |
20180263919 | THERAPEUTIC ELECTROSPUN FIBER COMPOSITIONS | 2018-09-20 |
20180263920 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING FENTANYL | 2018-09-20 |
20180263921 | Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of Rotigotine | 2018-09-20 |
20180263922 | TRANSDERMAL DELIVERY SYSTEM CONTAINING METHYLPHENIDATE OR ITS SALTS AND METHODS THEREOF | 2018-09-20 |
20180263923 | TRANSDERMAL DELIVERY SYSTEM CONTAINING METHYLPHENIDATE OR ITS SALTS AND METHODS THEREOF | 2018-09-20 |
20180263924 | METHODS OF TREATING METABOLIC SYNDROME RELATED CCONDITIONS USING RETINOIC ACID RECEPTOR AGONISTS | 2018-09-20 |
20180263925 | METHODS FOR THE TREATMENT OF ALOPECIA AREATA UTILIZING GENE MODULATION APPROACHES | 2018-09-20 |
20180263926 | Restoring Physiology in Iron-Deficient Organisms Using Small Molecules | 2018-09-20 |
20180263927 | AFFINITY MEDICANT CONJUGATE | 2018-09-20 |
20180263928 | AMANTADINE COMPOSITIONS AND METHODS OF USE | 2018-09-20 |
20180263929 | DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR | 2018-09-20 |
20180263930 | DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR | 2018-09-20 |
20180263931 | TOPICAL DAPSONE AND DAPSONE/ADAPLENE COMPOSITIONS AND METHODS FOR USE THEREOF | 2018-09-20 |
20180263932 | Method For Relieving Sinus Congestion | 2018-09-20 |
20180263934 | Necrosis Inhibitors | 2018-09-20 |
20180263935 | TREATMENT FOR MITOCHONDRIAL DISEASES | 2018-09-20 |
20180263936 | GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF DISORDERS | 2018-09-20 |
20180263937 | USE OF AN OLEOGEL CONTAINING TRITERPENE FOR HEALING WOUNDS | 2018-09-20 |
20180263938 | METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS | 2018-09-20 |
20180263939 | AUTOIMMUNE DISORDER TREATMENT USING RXR AGONISTS | 2018-09-20 |
20180263940 | TREATMENT OF SKIN CONDITIONS | 2018-09-20 |
20180263941 | Methods of Modulating miRNA Levels and Compositions for Use in the Same | 2018-09-20 |
20180263942 | MEDICAMENT FOR THERAPEUTIC TREATMENT OF NEUROPATHIC DISEASE | 2018-09-20 |
20180263943 | COMPOUND FOR TREATMENT OF MYOTONIC DYSTROPHY TYPE 1 | 2018-09-20 |
20180263944 | COMPOSITIONS AND METHODS FOR ACUTLEY RAISING NITRIC OXIDE LEVELS | 2018-09-20 |
20180263945 | PYRUVATE COMPOUNDS FOR TREATMENT OF PERIPHERAL NEUROPATHY | 2018-09-20 |
20180263946 | PHARMACEUTICAL COMPOSITIONS CONTAINING DIMETHYL FUMARATE | 2018-09-20 |
20180263947 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | 2018-09-20 |
20180263948 | METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS | 2018-09-20 |
20180263949 | METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS | 2018-09-20 |
20180263950 | METHODS FOR TREATING OR PREVENTING FATIGUE | 2018-09-20 |
20180263951 | METHOD OF QUENCHING SINGLET AND TRIPLET EXCITED STATES OF PHOTODEGRADABLE PIGMENTS, SUCH AS PORPHYRIN COMPOUNDS, PARTICULARLY PROTOPORPHYRIN IX, WITH CONJUGATED FUSED TRICYCLIC COMPOUNDS HAVING ELECTRON WITHDRAWING GROUPS, TO REDUCE GENERATION OF SINGLET OXYGEN | 2018-09-20 |
20180263952 | USE OF CANNABINOIDS IN THE TREATMENT OF INFLAMMATORY SKIN DISEASES | 2018-09-20 |
20180263953 | Sustained Release Cannabinoid Formulations | 2018-09-20 |
20180263954 | Sustained Release Cannabinoid Formulations | 2018-09-20 |
20180263955 | C-MYC As A Biomarker For Tumor Sensitivity To Treatment With RNA Polymerase II Inhibition | 2018-09-20 |
20180263956 | STABILIZED ASCORBIC ACID SOLUTIONS; COMPOSITIONS COMPRISING THE SAME; AND METHOD OF USE THEREOF | 2018-09-20 |
20180263957 | DULOXETINE SPRINKLES | 2018-09-20 |
20180263958 | METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR | 2018-09-20 |
20180263959 | METHODS OF TREATING MUSCULAR DYSTROPHY | 2018-09-20 |
20180263960 | Modulators of CA2+ Release-Activated CA2+ (CRAC) Channels and Pharmaceutical Uses Thereof | 2018-09-20 |
20180263961 | SELENIUM CONTAINING KGA/GDH DUAL INHIBITORS AND THE APPLICATIONS THEREOF | 2018-09-20 |
20180263962 | STABILIZED OXYMETAZOLINE FORMULATIONS AND THEIR USES | 2018-09-20 |
20180263963 | MODULATORS OF THE ADENOSINE A3 RECEPTORS | 2018-09-20 |
20180263964 | METHOD OF SCREENING FOR AGENTS FOR DIFFERENTIATING STEM CELLS | 2018-09-20 |
20180263965 | PHARMACEUTICAL COMPOSITION COMPRISING PYRIDONE DERIVATIVES | 2018-09-20 |
20180263966 | Inhibitors Of The Interaction Between MDM2 And P53 | 2018-09-20 |
20180263967 | HETEROCYCLIC COMPOUND | 2018-09-20 |
20180263968 | METHODS USING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE FOR TREATMENT OF MANTLE CELL LYMPHOMAS | 2018-09-20 |
20180263969 | COMPOSITIONS AND METHODS FOR TREATING BACTERIAL INFECTIONS | 2018-09-20 |
20180263970 | COMPOUNDS AND METHODS USEFUL FOR TREATING OR PREVENTING HEMATOLOGICAL CANCERS | 2018-09-20 |
20180263971 | COMBINATION OF TOPOISOMERASE-I INHIBITORS WITH IMMUNOTHERAPY IN THE TREATMENT OF CANCER | 2018-09-20 |
20180263972 | ANALOGS OF DEUTETRABENAZINE, THEIR PREPARATION AND USE | 2018-09-20 |
20180263974 | CRYSTALLINE SALTS OF NALOXONE AND NALTREXONE | 2018-09-20 |
20180263975 | Methods Of Treating Motor And Movement Disorders And Side Effects Thereof Associated with Parkinson's Disease Treatments | 2018-09-20 |
20180263976 | COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS | 2018-09-20 |
20180263977 | CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR | 2018-09-20 |
20180263978 | Bromocriptine Formulations | 2018-09-20 |